MedTrace Logo

Chronic Lymphoid Leukaemia Observatory in Finistere Area, France

NCT03294980 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2021-01-28

No results posted yet for this study

Summary

Brief Summary: The purpose of the OFICE registry is to characterize and describe the CLL patients' population from the Finistere area and evaluates the association between different patient characteristics, prognosis and treatment patterns.

Detailed Description: OFICE is a single center, prospective, observational registry of CLL patients designed to provide a general description of the CLL patients' population from the Finistere area, France. The registry will also provide information on the association of cytogenetic and immunophenotypic characteristics with disease progression, as well as treatment patterns and healthcare resource utilization. These data will be accessible and beneficial for researchers and physicians and will help guide clinical practice and future clinical or fundamental studies.

Conditions

  • Chronic Lymphoid Leukaemia

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Yves Reanudineau · CHRU de Brest

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03294980 on ClinicalTrials.gov